RB Launches Cough, Cold & Flu Navigator with WebMD

New Innovative and Intuitive Digital Tool Shortens Time Consumers Spend in Cold & Flu Aisle

NEW YORK, Dec. 22, 2020 /PRNewswire/ -- If 2020 has taught us all anything, it is that consumers want easy access to accurate information to help them navigate these uneasy times. Nowhere is that more prevalent that in the health and wellness space. To continue its mission of being a helper, Mucinex has created and launched The Cough, Cold, and Flu Navigator, a new digital tool designed to simplify and shorten consumer's OTC purchase experience, particularly important during this year's cold and flu season, when consumers may be less willing to spend time in store close to other shoppers. This innovative and intuitive resource extends the brand's partnership with WebMD.

Available within WebMD and via retail at-shelf integrations, the Cough, Cold & Flu Navigator addresses issues of OTC category clutter and a longer-than-average decision process at the shelf. This Navigator helps streamline the consumer experience with a personalized platform that shortens the purchase decision journey to help consumers quickly find the best ingredients and products to treat their symptoms.

How does the Navigator work? Consumers enter their symptoms and product preference type in a seamless digital process, which then determines which RB product would best help alleviate their symptoms (Mucinex DM, CÄ“pacol, Delsym 12-Hour, and others). If a consumer is unsure of their symptoms, the Navigator provides education on what each symptom is, what active ingredient is best to treat it, and even offers non-OTC remedies that could offer relief. In addition, consumers have the option to sign up to the Mucinex Mucus Fighters+ CRM program and receive a $5 digital coupon instantly via text to redeem in-store. In fact, this tool is the first branded mobile web-to-SMS-to-digital coupon for real-time redemption.

"In today's 'new normal,' innovations that simplify access to our family of products and provide accurate healthcare information are critical in helping our consumers," said Katelyn Ettenger, Senior Consumer Journey Manager, North America Health at RB. "We know the power of our products and using WebMD's technology to help consumers make better decisions, to champion self-care and most of all give them a sense of control continues to fulfill RB's mission of being a helper during these very turbulent times."

The Navigator continues this digital revolution in healthcare by building on the RB-sponsored WebMD Cold and Flu interactive map, which presents a real-time analysis of the spread of cold and flu symptoms using a combination of geo-location data and self-reported information from consumers experiencing influenza-like symptoms such as fever, sore throat and cough.

About RB

RB* is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.

RB is proud to have a stable of trusted household brands found in households in more than 190 countries. These include Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite, Air Wick and more. 20 million RB products a day are bought by consumers globally.

RB's passion to put consumers and people first, to seek out new opportunities, to strive for excellence in all that we do, and to build shared success with all our partners, while doing the right thing, always is what guides the work of our 40,000+ diverse and talented colleagues worldwide.

For more information visit www.rb.com/US

RB is the trading name of the Reckitt Benckiser group of companies

Contact: Amanda Pisano, apisano@legendpr.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rb-launches-cough-cold--flu-navigator-with-webmd-301197647.html

SOURCE Reckitt Benckiser

Back to news